Tag Archive for: evidence-based treatment

Banner Health Launches cliexa’s Adolescent Resiliency Screening Platform: cliexa-OPTIONS

Greeley, CO: cliexa today announces a new partnership with Banner Health’s North Colorado Family Medicine. This partnership supports a proof of concept study with cliexa’s adolescent resiliency digital health screening tool called cliexa-OPTIONS.

The study, which began on September 28, 2020 is sponsored by Dr. Michael Bradfield at Banner’s North Colorado Family Medicine, includes an independent evaluation team from the University of Northern Colorado. Dr. William Merchant from Applied Statistics and Research Methods, and Dr. Stephen Wright from the Applied Psychology and Counselor Education Program.

Doctoral students have been implementing cliexa-OPTIONS digital health screening at the Psychological Counseling Clinic since last year.

I find this tool is a valuable component to facilitating the process of reaching the client where they are developmentally. While working with youth requires integrated care and an interdisciplinary approach, the cliexa platform allows for a common and universal language to be used by all healthcare providers with the same mission of lowering sexual risk, empowering adolescents and young adults to make real behavioral changes, and increasing awareness of services that can be provided to them for additional support,” says Kaitlin Dent, a Doctoral student from the Applied Psychology and Counselor Education Program at UNC. “Clients feel safer, disclosing more personal and relevant information about their mental health, sexual activity, and overall well-being.

The benefits of this new partnership include:

  1. Implementation of the latest recommendations from the U.S. Preventive Services Task Force for adolescent behavioral health.
  2. Integrated care support to family physicians working with adolescent patients at Northern Colorado Family Medicine.
  3. Evaluating the quad aims, including cost-benefit, physician and patient satisfaction, and improving outcomes using digital screening tools that support primary care clinics.

We are excited to support Banner Health’s North Colorado Family Medicine. This proof of concept study is important for moving adolescent behavioral health and resiliency forward for primary care clinics,” says Mehmet Kazgan, CEO at cliexa.

About cliexa: cliexa is an end-to-end integrated virtual health platform that enables custom patient onboarding and remote patient monitoring, supporting multiple subspecialties including, pain, mental health, cardiology, adolescent behavioral health, podiatry, gastroenterology, and endocrinology. Learn more at cliexa.com.

About Banner North Colorado Family Medicine: is a cornerstone for family medicine health promotion, disease prevention, and chronic illness management for family members of all ages. Their team of ten physicians supports patients with their wellness and chronic care management. The clinic is located at 1600 23rd Ave Greeley, CO 80634, and includes a vibrant Family Medicine Residency Program. Learn more: Banner North Colorado

Featured image for patient-reported outcomes and AI in Pain Management

Integrated pain management is a specialty that has grown in recent years. Patient-reported outcomes and AI in pain management can provide insights to improve treatment plans. During each visit to a clinician, patients complete assessments to inform their provider about their current conditions. Each of these assessments creates a profile for the patient about their current and ongoing symptoms. Each of these patient-reported outcomes is extremely useful in tracking the success of a treatment plan. Recently, artificial intelligence (AI) has become an integral factor in learning more about these outcomes. AI can be trained to learn how different factors in a patient’s treatment plan affect their outcomes.

With pain management, it is essential to assess each patient’s pain symptoms frequently. By digitally recording responses to patient assessments, these patient-reported outcomes can be tracked more efficiently. To provide more effective treatment plans, pain management providers are using patient-reported outcomes and AI more often.

How does AI in healthcare work?

AI starts with compiling lots of data. In pain management, each time a patient visits their physician, they fill out assessments about their current symptoms and pain levels since their last visit. The provider then takes the information, compiles it, and compares it to each patient’s recent medication and lifestyle changes. In addition to this, the patient may utilize physical therapy or behavioral health resources in their treatment plan. All of these factors come into play when a provider makes decisions about the patient’s ongoing treatment will be. What has worked for them in the past? Are they improving? What else can they try?

This is where AI comes into play. AI and machine learning can take all of these factors and learn what can be an effective treatment plan for each patient. By compiling this data, AI can infer from previous assessments what is more or less likely to work for that patient based on their historical data.

AI recognizes patterns in treatment plans as data becomes available. Using this information can make a well-defined course of action for the healthcare provider. By utilizing these patient-reported outcomes and AI in pain management settings, treatment plans become more successful in pain patients.

Why is Pain Management a focus for AI?

Many different healthcare specialties can use AI with patient-reported outcomes. However, pain management tends to include a myriad of external factors for each patient. Pain management can include patients with medication dependencies, behavioral health diagnoses, and chronic diseases. Because of these factors, it is difficult to accurately weigh each one as a patient treatment plan is formed.

Because the opioid epidemic is a continuing concern for healthcare providers, AI has come into play more heavily. Digital healthcare has become a key player in combating the opioid crisis with remote patient monitoring and risk assessments. Correct dosing for opioid prescriptions is a fine line between addiction and chronic pain in patients. This is why AI has become prevalent in managing opioid use in hospital settings in recent years.

It’s also important to note that pain management is a very iterative an ongoing treatment process, and can differ greatly between patients. For this reason, collecting patient-reported outcomes to derive treatment options has proven to be successful in recent years.

How can I get started using AI in my practice?

cliexa’s pain management platform (cliexa-Ease) incorporates patient assessments and utilizes them to create a comprehensive risk score for each patient. The Symptom Severity Score (FIBR), Dallas Pain Questionnaire (DPS), Medical Outcomes Survey (MOS Core, SF-36), and Pain Disability Index (PDI) are all incorporated into the platform.

As a provider, you can create a risk matrix based on your treatment preferences and utilize this digital tool to streamline patient assessments and risk. Determining risk of a patient is the cornerstone to their treatment plan. Risk assessments assist the healthcare provider to make decisions based on many different factors that can affect a patient’s overall risk. Also, by tracking medication adherence and compliance with each patient will allow providers to better track their symptoms over time. All of these features are included in the cliexa-Ease platform and can help you to better track patient outcomes using remote monitoring and integrated risk assessments.

Learn more about cliexa’s digital platforms.

 

cliexa CEO featured in #AskTheCEO podcast

cliexa’s CEO & Founder, Mehmet Kazgan, is featured in the #AskTheCEO Podcast! The #AskTheCEO Podcast host is Avrohom Gottheil, CEO of #AskTheCEO Media.

In this #AskTheCEO episode, Mehmet and Avrohom sit down and discuss the importance of artificial intelligence in healthcare. During the conversation, the two talk about the importance of utilizing innovative technology. This technology is essential in order to stay at the forefront of patient care. As diseases and viruses continue to evolve over time, new healthcare technologies give rise to revolutionary developments. Data collection and AI capabilities are now moving at a pace to evolve and keep up with new diseases and viruses around the world. It is up to the healthcare industry to utilize tools like cliexa in order to compile data and start improving patient outcomes.

cliexa allows for efficient tracking of data, allowing physicians to compile information and make better, more informed decisions on patient treatment plans. This is based on patient outcomes, symptoms, and treatment plans over time. This way, physicians can collect data on what treatments are more effective than others. They can also track patient medication management

Through AI capabilities, cliexa can help to predict optimized treatment plans based on past data collected. Now that cliexa is available on the Azure Marketplace, more physicians and healthcare systems can implement this technology. The Azure Marketplace offers digital platforms to improve healthcare efficiency for users. To learn more about cliexa’s capabilities and how they can benefit patients, physicians, and payors, contact us to schedule a demo here.

 

 

 

American College of Cardiology Conference 2020

The American College of Cardiology (ACC) annual conference hosts colleagues from across the industry to collaborate and facilitate discussions around innovation. The ACC.20 conference takes place on March 28-30 in Chicago. cliexa is excited to announce that we will be attending for the second year in a row! Join cliexa at the ACC.20 conference and schedule a demo with our team here!

 

In addition, cliexa’s CEO & Founder, Mehmet Kazgan, will be participating in an open conversation at ACC.20 about mobile healthcare apps. A popular theme in today’s digital healthcare world is to discuss ways to increase patient engagement within a treatment plan. Therefore, the mobile healthcare industry is moving towards increased communication between patients and physicians through smartphone applications. cliexa’s technology allows for an integrated platform with any EMR that seamlessly connects patients and physicians. Equally important, the app improves the accuracy in patient data collection to utilize in reimbursements.

 

On Monday, March 30 from 9:45am – 11:15am, Mehmet will be participating in this open discussion with two other industry leaders on the topic of mobile healthcare applications. This ‘Knowledge and Networking’ session will be an interesting event to sit in on – and you can add it to your conference itinerary beforehand here. Along with Mehmet, the session leaders include Arash Harzand, MD, MBA, and Francoise Marvel, MD. Also, attendees will have the opportunity to ask questions and lead discussions around this engaging topic during the session.

 

UPDATE 3/9/2020: ACC.20 has been cancelled due to growing coronavirus concerns. Please visit the ACC website for updates and more information.

Researchers Receive $1 Million Grant to Study Digital Screening Intervention Tool for Adolescents and Young Adults

cliexa is excited to partner with the University of Northern Colorado (UNC) with a grant from the Department of Health and Human Services’ Office of Adolescent Health that provides nearly one million dollars over the next two years for the implementation of cliexa-OPTIONS, a digital screening intervention tool that fosters earlier identification of high-risk adolescents in a clinical setting. The funding supports independent evaluation including, cost-benefit analysis and randomized controlled trial of the cliexa-OPTIONS risk screening tool and MyPLAN mobile health follow-up. The Principal Investigator for the project at UNC is Dr. William Merchant. He is the evaluation professor in the Applied Statistics and Research Methods program in the College of Education and Behavioral Sciences. 

The cost-benefit analysis assesses cost savings between the cliexa-OPTIONS risk screening against current paper pencil and verbal screenings. Also, the cliexa-OPTIONS risk screening identifies 30- 50% more risk in adolescent populations fostering early identification of adolescents at highest risk for acquiring an STI or experiencing an unplanned pregnancy. Improving quality in clinical workflows for adolescent and young adult populations is timely, given that sexually transmitted infections for young people ages 15 -24 are at epidemic proportions.

Saving time and keeping providers satisfied with new technology in clinical workflows is no simple task. The cost-benefit analysis will also assess the benefits of early identification of adolescents at highest risk for adverse reproductive health outcomes, substance use, mental health, and wellness.

Read the full article at: //www.unco.edu/news/newsroom/releases/million-dollar-grant-digital-screening-intervention-tool.aspx